My work lies at the intersection of Anthropology and Science and Technology Studies (STS), with commitments to social theories of capitalism and postcolonial studies. I seek to understand the political economy of the contemporary life sciences and biomedicine, with a primary empirical focus on the United States and India. My focus has been to open up conceptual questions concerning the complex relationships between knowledge, health, value and politics. I have a three-fold set of intellectual commitments: (a) to explore the nature of scientific knowledge, practice and institutionalization; (b) to elucidate political economic structures that operate across multiple scales using ethnography; and (c) to theorize contemporary capitalism.
My recent book Pharmocracy: Value, Politics and Knowledge in Global Biomedicine, elucidates the political economy of global pharmaceuticals as seen from contemporary India. I develop the term “pharmocracy” to describe the global hegemony of the multinational, Euro-American, research and development (R & D)-driven pharmaceutical industry. It alludes to the ways in which this industry operates to institute forms of governance across the world that are beneficial primarily to its own interests. The book follows the global harmonization of clinical trials and of intellectual property regimes in India in the mid-2000s, arguing that these two moves must be understood in terms of this expansion of multinational corporate hegemony. “Third World” national regulations are now being instituted to facilitate First World corporate interests in ways that have consequences for state policy, industrial competitiveness and public health. However, this capitalization is not without contestation. The book traces ways in which pharmocracy comes to be politicized in India through trajectories of judicialization and public scandal, even as it instantiates and establishes itself as hegemonic.
Previously, I wrote Biocapital: The Constitution of Post-Genomic Life (Duke 2006), a multi-sited ethnography of genomics and post-genomic drug development marketplaces in the United States and India that tracks the nature and manner of the co-production of economic and epistemic value in contemporary life sciences. I am also the editor of Lively Capital: Biotechnologies, Ethics and Governance in Global Markets (Duke 2012).
Ongoing and future interests and projects include: Biomedical translational research: an ethnography of the institutionalization of biomedical translational research in India, following the establishment of India’s first translational research institute; Ethnographic methods pedagogy: I have conceptual interests in the teaching of ethnographic methods, including in conversation with other domains of practice that cultivate an embodied and empirical attentiveness to the world, such as photography; Judicialization of health: I am initiating a new research project, which will be a comparative study of the judicialization of health in India and South Africa.
My most ambitious pedagogical commitments have focused on the development of an ethnographic methods curriculum for graduate students. I have been teaching Anthropological Fieldwork Methods for the past decade, first at the University of California, Irvine, and then at Chicago. I teach elective seminars in Anthropology and social theory around a host of issues relating to contemporary capitalism and knowledge formations. My investments in undergraduate teaching lie primarily in teaching within the Colonizations core sequence, in addition to teaching an introductory STS class as part of the Anthropology major.
Selected Publications
2017
Pharmocracy: Trials of Global Biomedicine. Duke University Press.
2006
Biocapital: The Constitution of Post-Genomic Life. Duke University Press.
2012
(Ed.) Lively Capital: Biotechnologies, Ethics and Governance in Global Markets. Duke University Press.
2015
Trans-formations of Biology and of Theory. In D. Boyer, J. Faubioin and G. Marcus, eds., Theory is more than it used to be. Cornell University Press.
2014
(w/ Judith Farquhar) "Introduction" to Special Issue on Knowledge/Value: Information, Archives, Databases. East Asian Science, Technology and Society. 8(4): 383-89.
2013
(w/ Sabina Leonelli) Introduction: Biomedical Trans-actions, Postgenomics, and Knowledge/Value. Public Culture. 25(3): 463-476.
2012
Pharmaceutical Crises and Questions of Value: Terrains and Logics of Global Therapeutic Politics. South Atlantic Quarterly. 111(2):321-346.
2007
Experimental Values: Indian Clinical Trials and Surplus Health. New Left Review, 45: 67-88.
2005
Subjects of Speculation: Emergent Life Sciences and Market Logics in the US and India. American Anthropologist 107(1): 19-30.